Skip to main content
SpringerLink
Log in

Intracranial Renal Cell Cancer Metastasis

  • Chapter
Clinical Management of Renal Tumors

  • 762 Accesses

Abstract

Metastasis to the brain occurs in 5–10% of patients with renal cell carcinoma. Patients often present with localizing neurological signs or seizures. Increasingly, however, asymptomatic metastases are detected as oncologists are ordering more screening magnetic resonance and computed tomographic scans in renal cell carcinoma patients. The treatment for brain metastases from renal cell carcinoma includes whole brain radiation therapy, stereotactic radiosurgery, and surgical resection. Aggressive local treatment of renal cell carcinoma metastasis typically produces long periods of palliation if systemic disease can be controlled.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6–29.

    Article  PubMed  CAS  Google Scholar 

  2. Bennington JL. Cancer of the kidney: etiology, epidemiology and pathology. Cancer 1973;32:1017–1029.

    Article  PubMed  CAS  Google Scholar 

  3. Fujimi M, Akaza H, Yoshida M, et al. [Cerebellar metastasis from renal cell carcinoma.] Nippon Hinyokika Gakkai Zasshi 1986;77:1164–1168. (Jpn)

    Google Scholar 

  4. Gay PC, Litchy WJ, Cascino TL. Brain metastasis in hypernephroma. J Neurooncol 1987;5:51–56.

    Article  PubMed  CAS  Google Scholar 

  5. Marshall ME, Pearson T, Simpson W, et al. Low incidence of asymptomatic brain metastasis in patients with renal cell carcinoma. Urology 1990;36:300–302.

    Article  PubMed  CAS  Google Scholar 

  6. Masuda F, Arai Y, Ohnishi T, et al. [Brain metastasis from renal cell carcinoma.] Nippon Hinyokika Gakkai Zasshi 1984;75:278–282 (Japanese).

    PubMed  CAS  Google Scholar 

  7. Sawaya R, Bindal RK, Lang FF, et al. Metastatic brain tumors. In: Kaye AH, Laws ER, eds. Brain Tumors: An Encyclopedic Approach, 2nd ed. Edinburgh: Churchill Livingstone, 2001: 999–1026.

    Google Scholar 

  8. Shibui S, Nishikawa R, Nomura K. [Treatment for metastatic brain tumors from renal cell carcinoma.] No Shinkei Geka 1990;18:935–938 (Japanese).

    PubMed  CAS  Google Scholar 

  9. Yonese J, Kawakami S, Ueda T, et al. Clinical study of renal cell carcinoma with brain metastasis. Nippon Hinyokika Gakkai Zasshi 1995;86:1287–1293.

    PubMed  CAS  Google Scholar 

  10. Arbit E, Wronski M. Clinical decision making in brain metastasis. Neurosurg Clin North Am 1996;7:447–457.

    CAS  Google Scholar 

  11. Posner JB. Management of brain metastases. Rev Neurol 1992;148:477–487.

    PubMed  CAS  Google Scholar 

  12. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7(11): 1194–1201.

    Article  PubMed  CAS  Google Scholar 

  13. Ludwig HC, Akhavan-Shigari R, Rausch S, et al. Expression of focal adhesion kinase (p125 FAK) and proline rich tyrosine kinase 2 (PYK2/CAKb) in cerebral metastasis, correlation with VEGF-R-, ecNOSIII labeling and morphometric data. Anticancer Res 2000;20:1419–1424.

    PubMed  CAS  Google Scholar 

  14. Strugar J, Rothbart D, Harrington W, et al. Vascular permeability factor in brain metastasis: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994;81:560–566.

    Article  PubMed  CAS  Google Scholar 

  15. Mori Y, Kondziolka D, Lunsford LD, Logan T, Flickinger J. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 1998;83:344–353.

    Article  PubMed  CAS  Google Scholar 

  16. Perreti-Viton P, Margain D, Murayama N et al. Brain metastases. J Neuroradiol 1991;18:161–172.

    Google Scholar 

  17. Ferrara N. The role of vascular endothelial growth factor in the regulation of blood vessel growth. In: Bicknell R, Lewis CE, Ferrara N eds. Tumor Angiogenesis. New York: Oxford University Press, 1997:185–199.

    Google Scholar 

  18. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439–442.

    Article  PubMed  CAS  Google Scholar 

  19. Weisberg LA. Hemorrhagic metastatic neoplasms: Clinical computed tomographic correlations. Comput Radiol 1985;9(2):105–114.

    Article  PubMed  CAS  Google Scholar 

  20. Singh SK, Agris JM, Leeds NE et al. Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology 2000;217:50–53.

    PubMed  CAS  Google Scholar 

  21. Ostergaard L, Sorensen AG, Kwong KK et al. High-resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:716–725.

    Google Scholar 

  22. Hazle JD, Jackson EF, Schomer DF et al. Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging 1997;7:1084–1093.

    Article  PubMed  CAS  Google Scholar 

  23. Rock JP, Hearshen D, Scarpace L et al. Correlations between magnetic resonance spectroscopy and image guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51(4):912–919.

    Article  PubMed  Google Scholar 

  24. Uchino A, Hasuo K, Mizushima A et al. Intracranial metastasis of renal cell carcinoma: MR Imaging. Radiat Med 1996;14(2):71–76.

    PubMed  CAS  Google Scholar 

  25. Mintz AP, Cairncross JG. Treatment of a single brain metastasis. The role of radiation following surgical excision. JAMA 1998;280:1527–1529.

    Article  PubMed  CAS  Google Scholar 

  26. Markesbery WR, Brooks WH, Gupta GD et al. Treatment for patients with cerebral metastases. Arch Neurol 1978;35:754–756.

    PubMed  CAS  Google Scholar 

  27. Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 1965;18:298–306.

    Article  PubMed  CAS  Google Scholar 

  28. Glantz MJ, Cole BJ, Forsyth PA et al. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000;54(10):1886–1893.

    PubMed  CAS  Google Scholar 

  29. El Kamar FG, Posner JB. Brain metastasis. Semin Neurol 2004;24:347–362.

    Article  PubMed  Google Scholar 

  30. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann Neurol 1980;7:529–541.

    Article  PubMed  CAS  Google Scholar 

  31. Kurtz JM, Gelber R, Brady LW et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:891–895.

    PubMed  CAS  Google Scholar 

  32. Patchell RA, Tibbs PA, Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494–500.

    Article  PubMed  CAS  Google Scholar 

  33. Gaspar L et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745–751.

    PubMed  CAS  Google Scholar 

  34. Wronski M, Maor MH, Davis BJ et al. External radiation of brain metastasis from renal cell carcinoma: A retrospective study of 119 patients from the M.D. Anderson cancer center. Int J Radiat Oncol Biol Phys 1997;37:753–759.

    PubMed  CAS  Google Scholar 

  35. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31(4):983–998.

    PubMed  CAS  Google Scholar 

  36. McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neuro-Oncol 2004;68(1):41–47.

    Article  Google Scholar 

  37. Horsley V, Clarke RH. The structure and functions of the cerebellum examined by a new method. Brain 1908;31:45.

    Article  Google Scholar 

  38. Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316–319.

    PubMed  CAS  Google Scholar 

  39. Witham TF, Kondziolka D. Gamma knife radiosurgery. In: Winn HR, ed. Youmans’ Neurological Surgery, 5th ed, vol 4. Philadelphia: Saunders, 2004:4117–4121.

    Google Scholar 

  40. Lundford LD, Niranjan A. Radiosurgery of tumors. In: Winn HR ed. Youmans’ Neurological Surgery, 5th ed. Philadelphia: Saunders 2003:4055.

    Google Scholar 

  41. Chang SD, Adler JR. Robotics and radiosurgery—the cyberknife. Stereotact Funct Neurosurg 2001;76(3–4):204–208.

    Article  PubMed  CAS  Google Scholar 

  42. Novalis. New cancer treatment technique available at the Cleveland Clinic, Department of Radiation Oncology. www.clevelandclinic.org/radonc/novalis.

    Google Scholar 

  43. Cheng CW, Wong JR, Ndlovu AM et al. Dosimetric evaluation and clinical application of virtual mini multileaf collimator. Am J Clin Oncol 2003;26:37–44.

    Article  Google Scholar 

  44. Varlotto JM, Fleckinger JC, Niranjan A et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 2003;57:452–464.

    Article  PubMed  Google Scholar 

  45. Petrovich Z, Yu C, Gianotta SL et al. Survival and pattern of failure in brain metastasis treated with gamma knife radiosurgery. J Neurosurg 2002;97(5 suppl):499–506.

    PubMed  Google Scholar 

  46. Patchell RA, Cirrincione C, Thaler HT et al. Single brain metastases: surgery plus radiation or radiation alone. Neurology 1986;36:447–453.

    PubMed  CAS  Google Scholar 

  47. Bindal RK, Bindal BA, Sawaya R et al. Surgical treatment of multiple brain metastases. J Neurosurg 1993;79:210–216.

    Article  PubMed  CAS  Google Scholar 

  48. Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor S. Reoperation for recurrent metastatic brain tumors. J Neurosurg 1995;83:600–604.

    Article  PubMed  CAS  Google Scholar 

  49. Cushing H. Notes Upon a Series of Two Thousand Verified Cases with Surgical-Mortality Percentages Pertaining Thereto. Springfield, IL: Charles C Thomas 1932.

    Google Scholar 

  50. Brega K, Robinson WA, Winston K et al. Surgical treatment of brain metastases of malignant melanoma. Cancer 1990;66:2105–2110.

    Article  PubMed  CAS  Google Scholar 

  51. Hammoud MA, McCutcheon IE, Elsouki R et al. Colorectal carcinoma and brain metastases: Distribution, treatment and survival. Ann Surg Oncol 1996;3:453–463.

    Article  PubMed  CAS  Google Scholar 

  52. Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastasis from renal cell carcinoma in 50 patients. Urology 1996;47:187–193.

    Article  PubMed  CAS  Google Scholar 

  53. Grieg NH. Optimizing drug delivery to brain tumors. Cancer Treat Rev 1987;14:1–28.

    Article  Google Scholar 

  54. Papadopoulus I, Rudolph P, Weichert-Jacobsen K et al. Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon α-2 β and vinblastine. Urology 1996;48:373–378.

    Article  Google Scholar 

  55. Quesada JR, Swanson DA, Trinidade A, Gutterman JU. Renal cell carcinoma: antitumor effect of leukocyte interferon. Cancer Res 1983;43:940–947.

    PubMed  CAS  Google Scholar 

  56. Schmitz-Drager BJ, Jankevicius F, Otto T. Prognostsche Faktoren zur Vorhersage des Erfolges einer Immuntherapie biem metastasierten Nierenzellkarzinom [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcioma]. Urologe [A] 1995;34:195–199.

    CAS  Google Scholar 

  57. Murata J, Sawamura Y, Terasaka S, et al. Complete response of a large brain metastasis of renal cell cancer to interferon-alpha: case report. Surg Neurol 1999;51:289–291.

    Article  PubMed  CAS  Google Scholar 

  58. Guirgus LM, Yang JC, White DE et al. Safety and efficacy of high dose interleukin-2 therapy in patients with brain metastases. J Immunother 2002;25(1):82–87.

    Article  Google Scholar 

  59. Nanni C, Rubello D, Castellucci P et al. Role of (18)F-FDG PET-CT imaging for the detection of an unknown primary tumor: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 2005;32(5):589–592.

    Article  PubMed  CAS  Google Scholar 

  60. Som PM, Norton KI, Shugar JMA et al. Metastatic hypernephroma to the head and neck. AJNR Am J Neuroradiol 1987;8:1103–1106.

    PubMed  CAS  Google Scholar 

  61. Lauretti L, Fernandez E, Pallini R et al. Long survival in an untreated solitary choroid plexus metastasis from renal cell carcinoma: case report and review of literature. J Neuro-Oncol 2005;71:157–160.

    Article  Google Scholar 

  62. Basaria S, Westra WH, Brem H, Salvatori R. Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia. J Endocrinol Invest 2004;27(5):471–474.

    PubMed  CAS  Google Scholar 

  63. Marar IE, Kandil H, Kanal E, Marion D. Renal cell carcinoma metastatic to the pituitary gland: clinical manifestations and successful treatment with transsphenoidal resection. Endocr Pract 1998;4(4):204–207.

    PubMed  CAS  Google Scholar 

  64. Yokoyama T, Yoshino A, Katayama K et al. Metastatic pituitary tumor from renal cell carcinoma treated by fractionated stereotactic radiotherapy. Neurol Med Chir 2004;44:47–52.

    Article  Google Scholar 

  65. Crino PB, Sater RA, Sperling M et al. Renal cell carcinomatous meningitis: pathologic and immunohistochemical features. Neurology 1995;45(1):189–191.

    PubMed  CAS  Google Scholar 

  66. Kaplan JG, DeSouza TG et al. Leptomeningeal metastasis: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neuro-Oncol 1990;9:225–299.

    Article  CAS  Google Scholar 

  67. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25(2):103–119.

    Article  PubMed  CAS  Google Scholar 

  68. Brown MT, Coleman RE, Friedman AH et al. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. Clin Cancer Res 1996;2(6):963–972.

    PubMed  CAS  Google Scholar 

  69. Kramer K, Cheung NK, Humm JL et al. Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8. Med Pediatr Oncol 2000;35(6):716–718.

    Article  PubMed  CAS  Google Scholar 

  70. Moser R, Bruner JM, Grimm EA. Biologic therapy for brain tumors. Cancer Bull 1991;43:117–126.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, OH

    Kene Ugokwe MD & Steven A. Toms MD, MPH

Authors
  1. Kene Ugokwe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven A. Toms MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH

    Ronald M. Bukowski MD

  2. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH

    Andrew C. Novick MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Ugokwe, K., Toms, S.A. (2008). Intracranial Renal Cell Cancer Metastasis. In: Bukowski, R.M., Novick, A.C. (eds) Clinical Management of Renal Tumors. Humana Press. https://doi.org/10.1007/978-1-60327-149-3_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-149-3_29

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-251-3

  • Online ISBN: 978-1-60327-149-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation